Brian M. Culley

Companies

• Lineage Cell TherapeuticsBoard member Sep 19, 2018 to now¹
• Lineage Cell TherapeuticsChief executive officer Sep 19, 2018 to now¹
• Lineage Cell TherapeuticsPresident Sep 19, 2018 to now¹
• Manuka, Inc.Chief executive officer Sep 5, 2017 to Mar 19, 2018²
• Savara IncBoard member Dec 9, 2011 to Jan 23, 2017³
• Savara IncChief executive officer Feb 3, 2010 to Jan 23, 2017⁴
• Savara IncVP, Business Development Feb 2, 2006 to Jul 23, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LCLineage Cell Therapeutics LCTX255,516 shares⁶$253.0K at $0.99Mar 12, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 12, 2026Bought 15,000 shares at $1.63 of Lineage Cell Therapeutics⁶
• Feb 11, 2026Shares withheld for tax 12,869 shares at $1.80 of Lineage Cell Therapeutics⁷
• Feb 11, 2026Exercised options 31,250 shares of Lineage Cell Therapeutics⁷
• Dec 19, 2025Shares withheld for tax 334 shares at $1.68 of Lineage Cell Therapeutics⁸
• Dec 19, 2025Granted 8,925 shares of Lineage Cell Therapeutics⁸
• Feb 11, 2025Shares withheld for tax 12,547 shares at $0.65 of Lineage Cell Therapeutics⁹
• Feb 11, 2025Exercised options 31,249 shares of Lineage Cell Therapeutics⁹
• Nov 21, 2024Bought 40,000 shares at $0.60 of Lineage Cell Therapeutics¹⁰
• May 24, 2024Bought 10,000 shares at $1.05 of Lineage Cell Therapeutics¹¹
• Feb 11, 2024Shares withheld for tax 12,806 shares at $1.08 of Lineage Cell Therapeutics¹²
• Feb 11, 2024Exercised options 31,249 shares of Lineage Cell Therapeutics¹²
• Feb 11, 2023Shares withheld for tax 12,744 shares at $1.35 of Lineage Cell Therapeutics¹³
• Feb 11, 2023Exercised options 31,249 shares of Lineage Cell Therapeutics¹³
• Jun 30, 2022Shares withheld for tax 5,343 shares at $1.58 of Lineage Cell Therapeutics¹⁴
• Jun 30, 2022Exercised options 15,450 shares of Lineage Cell Therapeutics¹⁴
• Mar 31, 2022Bought 6,400 shares at $1.53 of Lineage Cell Therapeutics¹⁵
• Mar 31, 2022Shares withheld for tax 5,343 shares at $1.54 of Lineage Cell Therapeutics¹⁵
• Mar 31, 2022Exercised options 15,450 shares of Lineage Cell Therapeutics¹⁵
• Mar 25, 2022Bought 5,250 shares at $1.38 of Lineage Cell Therapeutics¹⁶
• Dec 31, 2021Shares withheld for tax 5,343 shares at $2.45 of Lineage Cell Therapeutics¹⁷
• Dec 31, 2021Exercised options 15,450 shares of Lineage Cell Therapeutics¹⁷
• Sep 30, 2021Shares withheld for tax 5,343 shares at $2.52 of Lineage Cell Therapeutics¹⁸
• Sep 30, 2021Exercised options 15,450 shares of Lineage Cell Therapeutics¹⁸